C07K 1 - General processes for the preparation of peptides

Patents for C07K 1 - General processes for the preparation of peptides (51,718)
12/2002
12/27/2002	CA2451524A1 Templated molecules and methods for using such molecules
12/27/2002	CA2450732A1 Stabilized proteins with engineered disulfide bonds
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/26/2002	US20020198363 Generation of antithrombic protein; obtain nucleotide sequences coding antithrombic protein, transform microorganism, express nucleotide sequences, recover protein
12/26/2002	US20020198360 Structural models for cytoplasmic domains of transmembrane receptors
12/26/2002	US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
12/26/2002	US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
12/26/2002	US20020197648 High throughput screening methods using magnetic resonance imaging agents
12/25/2002	CN1387399A Methods of producing target molecule in transgenic animal and purification of target molecule
12/25/2002	CN1386854A Earthworm DNA enzyme and its extracting process
12/25/2002	CN1386745A Process for extracting thallus from waste liquid of gourmet powder
12/24/2002	US6498236 Hybridoma cell culture supernatants, animal plasma or sera, or colostrum. the method includes the use of a minimum of salts, such as lyotropic salts, in the binding process and preferably also the use of small amounts of organic solvents in the
12/24/2002	US6498141 Method and apparatus for preparing an acellular red blood cell substitute
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002	US6497871 Polypeptide having anti-viral and anti-proliferative activity
12/24/2002	CA2147863C Determination of peptide motifs on mhc molecules
12/24/2002	CA2087261C Purification directed cloning of peptides
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/19/2002	WO2002101339A2 Imaging and analyzing parameters of small moving objects such as cells
12/19/2002	WO2002101021A2 Purification of human serum albumin
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002100883A2 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
12/19/2002	WO2002092615A3 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
12/19/2002	WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002	WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002	US20020193594 Process for the preparation of carboxamides
12/19/2002	US20020193564 Polypeptide for use in the treatment of muscular, huntington's and alzhemiers's diseases
12/19/2002	US20020193563 Randomly generated glycopeptide combinatorial libraries
12/19/2002	US20020192792 Laccase mutants
12/19/2002	US20020192759 Protein Fractionation
12/19/2002	US20020192714 Separation of polypeptides in sample; obtain sample, incubate with matrix, extract and recover polypeptides
12/19/2002	US20020192693 Apparatus for polymer synthesis
12/19/2002	US20020192684 Arrays for detecting nucleic acids
12/19/2002	US20020192673 Solid support for use in the generation of translated nucleic acid sequences
12/19/2002	US20020192315 Process for preparing cooagulants for water treatment
12/19/2002	US20020191048 High-throughput biomolecular crystallization and biomolecular crystal screening
12/19/2002	US20020189946 Microfluidic injection and separation system and method
12/19/2002	CA2449631A1 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
12/19/2002	CA2449272A1 Intracellular signaling molecules
12/19/2002	CA2448432A1 Purification of human serum albumin
12/18/2002	EP1267170A1 Method for characterising polypeptides
12/18/2002	EP1266666A2 Fibrin sealant compositions and method for utilizing same
12/18/2002	EP1266385A2 Porous ferro- or ferrimagnetic glass particles for isolating molecules
12/18/2002	EP1265913A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
12/18/2002	EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002	EP1265888A1 METHOD OF PRODUCING 6-SUBSTITUTED ( i S /i )-NICOTINE DERIVATIVES AND INTERMEDIATE COMPOUNDS
12/18/2002	EP1265684A1 Purification device and purification method
12/18/2002	EP1148945B1 New hydrophobic polymer comprising fluorine moieties
12/18/2002	EP1088020B1 Functionalised polymers of alpha-amino acids and the method of preparation thereof
12/18/2002	EP1073899A4 Improved method for purifying cholera toxin
12/18/2002	EP1068240B1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
12/18/2002	EP0866803B1 Transferrin receptor protein of moraxella
12/18/2002	EP0551440B1 Design of bioactive peptides based on immunoglobulin structure
12/18/2002	EP0521996B1 Catalytic antibody components
12/17/2002	US6495336 Oligopeptide derivatives for the electrochemical measurement of protease activity
12/17/2002	US6495314 Peptide ladder libraries corresponding to a protein, protein fragment, or other bioactive peptide and to the use of peptide ladder libraries for obtaining a protein signature analysis
12/17/2002	US6495129 Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
12/17/2002	CA2021722C Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices
12/17/2002	CA1341411C Method for producing fv fragments in eukaryotic cells
12/17/2002	CA1341410C Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
12/12/2002	WO2002099436A2 Characterising polypeptides
12/12/2002	WO2002099435A1 Method for characterizing polypeptides
12/12/2002	WO2002099124A2 Characterising polypeptides
12/12/2002	WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins
12/12/2002	WO2002098914A2 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002	WO2002098904A1 Method for separating, purifying and identifying proteins from protein mixtures
12/12/2002	WO2002098903A1 Method of preparing peptide with high yield and high purity using 2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids
12/12/2002	WO2002098902A2 Improved native chemical ligation with three or more components
12/12/2002	WO2002098531A1 Methods for purifying highly anionic proteins
12/12/2002	WO2002098446A1 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	WO2002098437A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002	WO2002057737A3 Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis
12/12/2002	WO2002053723A3 Degradation and detection of tse infectivity
12/12/2002	WO2002053288A3 A method for the manufacture of compositions containing low concentrations of salts
12/12/2002	WO2002030983A3 Plasma fraction containing bikunin, method for the production thereof and use of the same
12/12/2002	US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002	US20020187501 Microdevices having a preferential axis of magnetization and uses thereof
12/12/2002	US20020187198 Site specific ligation of proteins to synthetic particles
12/12/2002	CA2449942A1 Characterising polypeptides
12/12/2002	CA2449681A1 Characterising polypeptides
12/12/2002	CA2449680A1 Method for characterizing polypeptides
12/12/2002	CA2449290A1 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002	CA2448044A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	CA2446152A1 Improved native chemical ligation with three or more components
12/11/2002	EP1265072A1 Method for characterising polypeptides
12/11/2002	EP1264839A1 Method for separating protein mixtures
12/11/2002	EP1264838A1 Protein hydrolyzates, process for producing the same and drinks and foods containing the protein hydrolyzates
12/11/2002	EP1264837A1 Conjugation-stabilized polypeptide compositions
12/11/2002	EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002	EP1263883A1 Carboxyl-modified superabsorbent protein hydrogels
12/11/2002	EP1263800A1 A new linker based solid support for peptide and small molecule organic synthesis
12/11/2002	EP1263771A2 Chemoselective ligation by use of a phosphine
12/11/2002	EP1263452A2 Methods and compositions for generating angiostatin
12/11/2002	EP0788511B1 Cyclic hexapeptides having antibiotic activity
12/11/2002	EP0591431B1 Hepatitis c virus (hcv) polypeptides
12/10/2002	US6492491 Method of making hypusine peptides
12/10/2002	US6492490 Liquid phase peptide syntheses of KL-4 pulmonary surfactant
12/10/2002	US6492489 Synthetic hypusine peptides
12/10/2002	US6492460 Polystyrene solid support

1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 518